IMC · ASX

Immuron Limited (ASX:IMC)

AU$0.078

 0.0 (0.0%)
ASX:Live
20/12/2024 01:08:19 PM
HALO Ords HALO Consensus Value GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IMC Overview

IMC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About IMC

Website

N/A

Telephone

61.3.8892.4802

Address

25-37 Chapman Street Building 10 Blackburn North, Victoria (VIC) 3131

Description

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce on mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994, and is headquartered in Carlton, Australia.

IMC Price Chart

Key Stats

Market Cap

AU$18.56M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.06 - 0.17

Trade Value (12mth)

AU$13,751.00

1 week

-7.14%

1 month

4%

YTD

1.3%

1 year

1.3%

All time high

15.60

Key Fundamentals

EPS 3 yr Growth

-19.80%

EBITDA Margin

-175.00%

Operating Cashflow

-$6m

Free Cash Flow Return

-34.10%

ROIC

-42.50%

Interest Coverage

-1,132.30

Quick Ratio

4.90

Other Data

Shares on Issue (Fully Dilluted)

228m

HALO Sector

Healthcare

Next Company Report Date

29-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IMC Announcements

Latest Announcements

Date Announcements

10 December 24

Notification regarding unquoted securities - IMC

×

Notification regarding unquoted securities - IMC

10 December 24

Change of Director's Interest Notice (JJ)

×

Change of Director's Interest Notice (JJ)

10 December 24

Change of Director's Interest Notice (DP)

×

Change of Director's Interest Notice (DP)

10 December 24

Change of Director's Interest Notice (RS)

×

Change of Director's Interest Notice (RS)

22 November 24

Immuron CEO presentation to Virtual Investor Summit

×

Immuron CEO presentation to Virtual Investor Summit

18 November 24

2024 AGM Presentation

×

2024 AGM Presentation

18 November 24

Results of Meeting

×

Results of Meeting

14 November 24

Notification of cessation of securities - IMC

×

Notification of cessation of securities - IMC

14 November 24

Change of Director's Interest Notice (DP RS)

×

Change of Director's Interest Notice (DP RS)

29 October 24

Notification regarding unquoted securities - IMC

×

Notification regarding unquoted securities - IMC

23 October 24

Change in substantial holding

×

Change in substantial holding

18 October 24

Notice of Annual General Meeting

×

Notice of Annual General Meeting

16 October 24

IMC CEO to participate in Maxim Healthcare Conference

×

IMC CEO to participate in Maxim Healthcare Conference

16 October 24

IMC CEO to participate in Maxim Healthcare - addendum

×

IMC CEO to participate in Maxim Healthcare - addendum

15 October 24

Immuron Travelan continued strong sales growth

×

Immuron Travelan continued strong sales growth

08 October 24

Application for quotation of securities - IMC

×

Application for quotation of securities - IMC

08 October 24

Notice under section 708A

×

Notice under section 708A

04 October 24

NMRC Reports Results for Campylobacter Clinical Study

×

NMRC Reports Results for Campylobacter Clinical Study

03 October 24

Trading Halt

×

Trading Halt

30 September 24

Annual Report

×

Annual Report

30 September 24

Corporate Governance Statement

×

Corporate Governance Statement

30 September 24

Appendix 4G

×

Appendix 4G

26 September 24

Immuron CEO presentation to Emerging Growth Conference

×

Immuron CEO presentation to Emerging Growth Conference

05 September 24

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

×

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

30 August 24

Appendix 4E and Preliminary Final Report

×

Appendix 4E and Preliminary Final Report

IMC Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.02 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.02 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 67.0 -32.8 -83.1 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 49.1 -35.8 -40.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -17.5 -14.6 -27.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.10 0.09 0.06 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.10 0.09 0.06 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.7 -15.4 -35.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 228 228 228 Lock Lock Lock
Basic m Lock Lock Lock Lock 228 228 228 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 1 2 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 424.9 135.8 171.7 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 5 8 12 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 1 1 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 452.8 150.1 154.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 68.4 72.5 68.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 32 27 32 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 -6 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 51.8 -47.6 -44.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -527.0 -329.8 -175.0 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -4 -6 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 51.8 -47.8 -43.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -530.5 -332.5 -175.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -4 -6 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -3 -4 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 66.0 -32.7 -83.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -373.0 -209.8 -141.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 -2 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 -3 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -2 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.2 20.6 -122.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4.1 -1.4 -1.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 22 19 12 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 25 22 16 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -22 -19 -11 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 2 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 23 20 13 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 23 20 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.8 -15.4 -35.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -11.5 -17.2 -44.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -12.3 -19.3 -54.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -16.5 -27.8 -52.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -11.6 -17.6 -42.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -12.7 -11.5 -34.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -652.1 -616.6 -1,132.3 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 5.4 3.2 1.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -94.5 -95.9 -90.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 15.8 9.2 5.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 15.5 8.8 4.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 93.4 93.1 79.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -208.4 -112.1 -206.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.5 3.3 5.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.8 0.8 1.3 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.4 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 94.2 43.8 13.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.3 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -406.7 -213.6 -127.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -12.5 -17.5 -40.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -11.5 -17.2 -44.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -12.3 -19.3 -54.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -12.3 -19.3 -54.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 467.5 429.6 282.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 237.9 109.2 67.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 705.4 538.9 349.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 547.9 273.4 113.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 157.5 265.4 236.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IMC Shortsell

Frequently Asked Questions

The current share price of Immuron Limited (IMC:ASX) is AU$0.078.
The 52-week high share price for Immuron Limited (IMC:ASX) is AU$0.17.
The 52-week low share price for Immuron Limited (IMC:ASX)? is AU$0.06.
Immuron Limited (IMC:ASX) does not pay a dividend.
Immuron Limited (IMC:ASX) does not pay a dividend.
Immuron Limited (IMC:ASX) has a franking level of 0.0%.
Immuron Limited (IMC:ASX) is classified in the Healthcare.
The current P/E ratio for Immuron Limited (IMC:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.